IART · Integra Lifesciences Holdings Corp

$18.82 -0.19 (-1.00%) At close · Jul 22

Market Cap

$1.46B

77.80M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mojdeh Poul	CEO	$1,009,616	$350,438	$5,219,868	$2,250,011	$174,563	$371,056	$9,375,551
Lea Knight	CFO	$638,646	$154,897	$1,498,719	$499,574	$77,158	$14,000	$2,882,994
Harvinder Singh	Executive Vice President & President, International	$563,993	$91,194	$683,126	$227,704	$45,426	$14,000	$1,625,444
Jan De Witte	CEO	$42,308	—	—	—	—	$240,372	$282,679

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jan De Witte	CEO	$968,998	—	$4,500,045	$1,500,012	$491,250	$34,363	$7,494,668
Michael McBreen	Executive Vice President, President, Codman Specialty Surgical	$638,702	$222,705	$1,627,799	$442,584	$215,045	$13,455	$3,160,291
Lea Knight	CFO	$616,662	$281,942	$1,584,589	$428,189	$220,284	$13,800	$3,145,466
Harvinder Singh	Executive Vice President & President, International	$511,088	$134,310	$1,375,853	$258,610	$129,690	$214,631	$2,624,181
Robert T. Davis	Executive Vice President, President, Tissue Technologies	$544,944	$134,803	$1,203,880	$234,620	$130,167	$13,800	$2,262,214

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jan De Witte	CEO	$875,467	—	$4,125,076	$1,375,013	—	$13,200	$6,388,756
Michael McBreen	Executive Vice President, President, Codman Specialty Surgical	$598,077	—	$1,789,174	$429,701	—	$13,200	$2,830,152
Lea Knight	CFO	$295,385	$350,000	$1,000,000	—	—	$27,762	$1,673,147
Eric I. Schwartz	Executive Vice President, Chief Legal Officer and Secretary	$536,318	—	$804,100	$268,002	—	$13,200	$1,621,620
Robert T. Davis	Executive Vice President, President, Tissue Technologies	$515,990	—	$670,392	$223,439	—	$13,062	$1,422,883
Jeffrey Mosebrook	Chief Accounting Officer	$368,050	$111,888	$760,156	—	—	$13,200	$1,253,294
Carrie Anderson	CFO	$64,692	—	—	—	—	$2,588	$67,280

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jan De Witte	CEO	$850,000	—	$6,500,093	$1,000,014	$813,450	$156,356	$9,319,913
Glenn Coleman	COO	$463,500	—	$1,390,554	$463,512	$430,128	$1,677,870	$4,425,564
Eric I. Schwartz	Executive Vice President, Chief Legal Officer and Secretary	$525,000	—	$1,912,606	$637,500	$310,000	$12,200	$3,397,306
Carrie Anderson	CFO	$565,404	—	$1,968,080	$406,010	—	$12,200	$2,951,694
Michael McBreen	Executive Vice President, President, Codman Specialty Surgical	$494,469	—	$1,150,884	$216,929	$274,100	$12,200	$2,148,582
Robert T. Davis	Executive Vice President, President, Tissue Technologies	$498,030	—	$938,496	$212,809	$271,000	$12,200	$1,932,535

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Arduini	CEO	$956,308	—	$5,750,092	$1,500,021	$1,621,200	$11,600	$9,839,221
Glenn Coleman	COO	$613,292	—	$1,761,407	$463,502	$688,000	$11,267	$3,537,468
Carrie Anderson	CFO	$518,462	—	$1,246,979	$328,142	$515,000	$28,081	$2,636,663
Robert T. Davis	Executive Vice President, President, Tissue Technologies	$487,022	—	$875,970	$208,551	$375,000	$11,301	$1,957,844
Michael McBreen	Executive Vice President, President, Codman Specialty Surgical	$459,969	—	$827,483	$197,007	$385,000	$10,908	$1,880,367
Jan De Witte	CEO	$58,846	—	—	—	$144,384	$48,543	$251,773

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Arduini	CEO	$848,077	—	$4,200,065	$1,800,003	$882,000	$10,554	$7,740,699
Glenn Coleman	COO	$559,615	—	$1,330,034	$570,010	$360,000	$8,331	$2,827,990
Carrie Anderson	CFO	$466,346	—	$875,046	$375,003	$262,500	$81,860	$2,060,755
Robert T. Davis	Executive Vice President, President, Tissue Technologies	$449,600	—	$483,061	$207,008	$214,508	$11,400	$1,365,577
Michael McBreen	Executive Vice President, President, Codman Specialty Surgical	$385,308	—	$547,553	$127,512	$202,500	$11,400	$1,274,273

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Arduini	CEO	$975,000	—	$3,990,017	$1,710,006	$1,176,000	$8,400	$7,859,423
Glenn Coleman	COO	$585,426	—	$1,654,286	$387,506	$482,000	$11,200	$3,120,418
Robert T. Davis	Executive Vice President, President, Tissue Technologies	$473,213	—	$453,598	$194,390	$258,000	$11,200	$1,390,401
Daniel L. Reuvers	Executive Vice President and President — Codman Specialty Surgical	$445,250	—	$416,585	$178,517	$290,000	$11,200	$1,341,552

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Arduini	CEO	$947,916	—	$3,815,037	$1,635,003	$1,232,640	$17,216	$7,647,812
Glenn Coleman	COO	$556,200	—	$869,428	$372,612	$480,730	$15,700	$2,294,670
Daniel L. Reuvers	Executive Vice President and President — Codman Specialty Surgical	$418,920	—	$892,085	$168,011	$326,000	$13,363	$1,818,379
Robert T. Davis	Executive Vice President, President, Tissue Technologies	$458,350	—	$437,582	$187,504	$272,000	$13,980	$1,369,416
Eric I. Schwartz	Executive Vice President, Chief Legal Officer and Secretary	$57,212	$180,000	$900,008	—	—	—	$1,137,220

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Arduini	CEO	$905,024	—	$3,325,053	$1,425,003	$1,463,422	$16,066	$7,134,568
Glenn Coleman	COO	$536,250	—	$805,022	$345,000	$590,000	$10,950	$2,287,222
Robert T. Davis	Executive Vice President, President, Tissue Technologies	$441,250	—	$437,543	$187,501	$360,000	$8,000	$1,434,294
Daniel L. Reuvers	Executive Vice President and President — Codman Specialty Surgical	$407,258	—	$262,560	$112,514	$375,000	$117,726	$1,275,058

Executive changes

Person	Role	Change	Effective	Filed
Christian S. Schade	director of the Board of Directors	Appointed	2026-05-07	2026-05-08
Renee W. Lo	director of the Board of Directors	Appointed	2026-05-07	2026-05-08
Jeffrey A. Graves, Ph.D.	director of the Board of Directors	Appointed	2026-05-07	2026-05-08
Stuart M. Essig, Ph.D.	director of the Board of Directors	Appointed	2026-05-07	2026-05-08
Barbara B. Hill	director of the Board of Directors	Appointed	2026-05-07	2026-05-08
Shaundra D. Clay	director of the Board of Directors	Appointed	2026-05-07	2026-05-08
Keith Bradley, Ph.D.	director of the Board of Directors	Appointed	2026-05-07	2026-05-08
Stuart M. Essig	President and Chief Executive Officer	Appointed	2026-05-01	2026-05-05

Key facts CIK 917520 CUSIP 457985208 13F (30d) 28 filings 28 filers Visit website Investor relations